NK Cell Frequencies, Function and Correlates to Vaccine Outcome in BNT162b2 mRNA Anti-SARS-CoV-2 Vaccinated Healthy and Immunocompromised Individuals

Scientists characterized NK cells in healthy individuals and immunocompromised patients in the course of an anti-SARS-CoV-2 BNT162b2 mRNA prospective, open-label clinical vaccine trial.